Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks

Polycystic ovary syndrome (PCOS) was identified as a condition characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries, with associated infertility treatable through modern reproductive techniques. Hirsutism in PCOS could be managed with medications targeting ovarian function and androgen activity. There was an established link between PCOS and endometrial cancer, and a possible link to breast cancer. Women with PCOS shared features with the metabolic syndrome, notably an increased prevalence of type 2 diabetes, although no increased mortality from cardiovascular disease was found. Lifestyle changes and insulin sensitizers showed promise in managing PCOS, but further long-term studies were needed.